...
首页> 外文期刊>Vaccine >Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+T cells in vivo
【24h】

Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+T cells in vivo

机译:乙肝病毒(HBV)衍生的DRB1 * 0101限制性CD4 T细胞表位有助于体内HBV特异性CD8 + T细胞的发育

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We previously identified two HLA-DRB1*0101-restricted epitopes in hepatitis B virus (HBV) X protein (HBx) and in HBV envelope proteins (preS2). To evaluated their help in the development of CD8+ T-cell responses, mice transgenic for human class I and class II HLA molecules were immunized with HBV-T helper constructs. The preS2 epitope favored a well-balanced response with CD4+ and CD8+ T cells producing IFN-gamma, IL-2 and TNF-alpha. The response was focused on CD8+ T cells with the HBx epitope. Fine characterization of helper activities may meet clinical needs in terms of enhancing the potency of preventive or therapeutic polyepitope vaccines.
机译:我们先前在乙型肝炎病毒(HBV)X蛋白(HBx)和HBV包膜蛋白(preS2)中鉴定了两个HLA-DRB1 * 0101限制的表位。为了评估其对CD8 + T细胞应答发展的帮助,使用HBV-T辅助构建体免疫了针对人类I类和II类HLA分子的转基因小鼠。 preS2表位有利于产生IFN-γ,IL-2和TNF-α的CD4 +和CD8 + T细胞的平衡应答。反应集中在具有HBx表位的CD8 + T细胞上。就增强预防或治疗性多表位疫苗的效力而言,辅助活动的精细表征可满足临床需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号